Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Bayley

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Genes, Chromosomes & Cancer|July 30, 2008
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locusRogier A Oldenburg, Karin H G Kroeze-Jansema, Jeanine J Houwing-Duistermaat, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2011
SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomasEsther Korpershoek, Judith Favier, José Gaal, et al.
Oncotarget|October 17, 2015
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumorsAttje S Hoekstra, Marieke A de Graaff, Inge H Briaire-de Bruijn, et al.
Oncotarget|January 19, 2017
Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomasAttje S Hoekstra, Erik F Hensen, Ekaterina S Jordanova, et al.
European Journal of Endocrinology|May 12, 2017
The phenotype of <i>SDHB</i> germline mutation carriers: a nationwide studyNicolasine D Niemeijer, Johannes A Rijken, Karin Eijkelenkamp, et al.
Endocrine-Related Cancer|May 26, 2018
65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytomaHartmut P Neumann, William F Young, Tobias Krauss, et al.
European Journal of Endocrinology|October 8, 2013
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysisThomas G Papathomas, Jose Gaal, Eleonora P M Corssmit, et al.
The Lancet. Oncology|January 15, 2010
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytomaJean-Pierre Bayley, Henricus P M Kunst, Alberto Cascon, et al.
The Lancet. Oncology|July 7, 2009
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysisFrancien H van Nederveen, José Gaal, Judith Favier, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Genes, Chromosomes & Cancer|July 30, 2008
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locusRogier A Oldenburg, Karin H G Kroeze-Jansema, Jeanine J Houwing-Duistermaat, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2011
SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomasEsther Korpershoek, Judith Favier, José Gaal, et al.
Oncotarget|October 17, 2015
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumorsAttje S Hoekstra, Marieke A de Graaff, Inge H Briaire-de Bruijn, et al.
Oncotarget|January 19, 2017
Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomasAttje S Hoekstra, Erik F Hensen, Ekaterina S Jordanova, et al.
European Journal of Endocrinology|May 12, 2017
The phenotype of <i>SDHB</i> germline mutation carriers: a nationwide studyNicolasine D Niemeijer, Johannes A Rijken, Karin Eijkelenkamp, et al.
Endocrine-Related Cancer|May 26, 2018
65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytomaHartmut P Neumann, William F Young, Tobias Krauss, et al.
European Journal of Endocrinology|October 8, 2013
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysisThomas G Papathomas, Jose Gaal, Eleonora P M Corssmit, et al.
The Lancet. Oncology|January 15, 2010
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytomaJean-Pierre Bayley, Henricus P M Kunst, Alberto Cascon, et al.
The Lancet. Oncology|July 7, 2009
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysisFrancien H van Nederveen, José Gaal, Judith Favier, et al.
Pageof 5